Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000377332 | SCV000472162 | uncertain significance | Intellectual Disability, Recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000504491 | SCV000597535 | uncertain significance | not specified | 2016-12-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314083 | SCV000848015 | likely benign | Inborn genetic diseases | 2018-01-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV002058704 | SCV002459925 | likely benign | not provided | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003922622 | SCV004744726 | likely benign | TRAPPC9-related disorder | 2022-05-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |